Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2024 16:31 ET
|
Chimerix, Inc.
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement...
Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson
October 18, 2024 09:06 ET
|
Can-Fite BioPharma Ltd.
Data Reported by Can-Fite Veterinary Partner Vetbiolix who already exercised its option for a full license deal worth $325M Ramat Gan, Israel, Oct. 18, 2024 (GLOBE NEWSWIRE) --...
Valneva and LimmaTech Awarded FDA Fast Track Designation for Tetravalent Shigella Vaccine Candidate S4V
October 16, 2024 11:45 ET
|
VALNEVA
Saint Herblain (France) and Schlieren (Zurich), October 16, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech...
Ikerian Announces Series B Funding First close of USD 8M (CHF 6.73M) Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe
October 16, 2024 03:00 ET
|
Ikerian AG
First close Series B funding round raises USD 8M (CHF 6.73M) led by new investor, Sanoptis, with participation from existing investors the THINC Ventures arm of Topcon Healthcare, Inc, Zürcher...
KFNCCC A Regional Leader in Pediatric Cancer Treatment
October 15, 2024 09:18 ET
|
King Faisal Specialist Hospital & Research Centre
KFNCCC A Regional Leader in Pediatric Cancer Treatment
Adaptive Research Launches Decentralized Clinical Trial in Parkinson’s Disease
October 15, 2024 08:30 ET
|
Adaptive Research Inc
Adaptive Research announced its participation in a decentralized study for Parkinsons’ Disease sponsored by PhotoPharmics Inc.
CenTrak Named Global Healthcare RTLS Company of the Year by Frost & Sullivan
October 10, 2024 09:05 ET
|
CenTrak, Inc.
CenTrak recognized as a global RTLS leader for its scalable location data and comprehensive suite of solutions on a unified platform
Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders
October 10, 2024 07:13 ET
|
Appili Therapeutics Inc.
Your vote is important no matter how many votes you hold.Shareholders who have questions or need assistance with voting their shares should contact info@appilitherapeutics.com HALIFAX, Nova Scotia,...
Valneva Hosts Investor Day in New York City
October 10, 2024 01:00 ET
|
VALNEVA
Live event and webcast TODAY at 10 AM ET Saint Herblain (France), October 10, 2024 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, is hosting an investor day today in...
FDA Grants Orphan Drug Designation to Can-Fite’s Namodenoson for Pancreatic Cancer
October 09, 2024 07:00 ET
|
Can-Fite BioPharma Ltd.
RAMAT GAN, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...